🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The pharmacy bat signal when the University of Kentucky Cardiology Fellowship fellows need help 😄 UK_GillHeart ACCP Cardiology PRN

⚠️ An Australian-New Zealand study calls for caution when using anticoagulants or DAPT with ticagrelor in patients with a history of SCAD ⚠️ Read the details here and share your thoughts 💭 #WNW academic.oup.com/eurheartj/arti…

Intensive medical therapy did not significantly impact the rate of serious CV events at five years in women w/ suspected INOCA, according to findings from WARRIOR presented during a #LBCT session at #ACC25. Learn more: bit.ly/3DXMI49

My preferred shock team for #ACC25 #GurleysGirlies #CardioTwitter Ammar Hasnie, MD Ashley Schenk, PharmD, BCCP, AACC Brooke UK_GillHeart University of Kentucky Cardiology Fellowship

Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study presented during a Late-Breaking Clinical Trial session at #ACC25. Check out the key findings ➡️ bit.ly/3DYGHEl

One of the most important trials at American College of Cardiology #ACC25 ! Compared fluid restriction to liberal approach in #HeartFailure. Why? This affects individuals w/HF EVERY DAY! ✨No benefit of Fluid Restriction ✨No HARM for liberal fluid intake ✨Improved QOL in liberal fluid intake

.University of Kentucky Cardiology Fellowship representing on Day 1 of #ACC25 with FIT Jeopardy, LBCTs, and CCU escape room. American College of Cardiology Kentucky Chapter ACC

Presented at #ACC25: Among adults with pulmonary arterial hypertension at high risk for death, sotatercept reduced the risk of a composite of death from any cause, lung transplantation, or pulmonary arterial hypertension. Full ZENITH trial results: nej.md/4iYkLbj

🌟 Attention students and residents 🌟 The Student and Trainee Committee is offering 2️⃣ travel grants to the 2025 ACCP Annual Meeting in Minneapolis, MN! See the attached flyer for more information and don't miss out on this excellent opportunity! 📑

Hey pharmacists! Check out this webinar on how to start a heart failure clinic: hfsa.org/event/hfsa-pha… U-M College of Pharmacy ACCP Cardiology PRN Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP,CACP Paul Forsyth AACP

Available head-to-head RCTs comparing non-steroidal MRA finerenone versus steroidal MRA spironolactone #HeartFailure2025

CATHEDRAL-HF: Withdrawal of other #HeartFailure treatment while maintaining carvedilol as a single therapy did not worsen left ventricular function compared to usual treatment at 52 weeks in patients w/ HFimpEF. Read more: bit.ly/44IEuId #JACCHF JACC Journals

🌟 A new Perioperative management of GLP1s consensus statement has just dropped In those taking GLP1s without gastrointestinal symptoms (nausea, vomiting): GLP1s should be continued perioperatively 24 hour fast for solids 4 hour fast of clear liquids before general anesthesia

Happy #TBT! This week is the ERICA trial. In patients with angina refractory to max dose amlodipine, addition of ranolazine reduced frequency of angina and NTG use. When do you use ranolazine in your practice? TY to Lexi Lahey for making this infographic! #CardioTwitter #CCD

GLP-1 receptor agonists are linked to rare cases of euglycemic ketoacidosis, even in patients without diabetes. This review highlights the importance of recognizing euglycemic DKA in patients who take GLP-1 medications. nature.com/articles/s4136…

REVIEW: Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management? ahajrnls.org/3Tvoxy5

Do statins cause diabetes? 🤔 No! According to the USPSTF meta-analysis there was no increase in incident diabetes with statin therapy. The fear of getting diabetes should not dissuade patients from starting lipid lowering treatment. #ADASciSessions #ADA2025

Is this the end of rivaroxaban for acute VTE? Lana Castellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025

Flecainide use had a favorable safety profile and was associated with a significant reduction in arrhythmic burden in patients with ARVC, irrespective of the underlying genotype or LV involvement. jacc.org/doi/10.1016/j.… #JACCCEP #EPeeps #cardiomyopathy

Looking to join a fantastic cardiology pharmacy team? 🫀We are looking for an Advanced Heart Failure/LVAD/Transplant pharmacist. See linked posting below! UK HealthCare Pharmacy Services UK ICU Pharmacy UK_GillHeart ACCP Cardiology PRN University of Kentucky College of Pharmacy ukjobs.uky.edu/postings/591164